false 2024 --09-30 Q3 0001497649 0001497649 2023-10-01 2024-06-30 0001497649 2024-10-07 0001497649 2024-06-30 0001497649 2023-09-30 0001497649 2024-04-01 2024-06-30 0001497649 2023-04-01 2023-06-30 0001497649 2022-10-01 2023-06-30 0001497649 us-gaap:CommonStockMember 2023-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001497649 GSTX:StockReceivableMember 2023-09-30 0001497649 GSTX:StockPayableMember 2023-09-30 0001497649 us-gaap:RetainedEarningsMember 2023-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001497649 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001497649 GSTX:StockReceivableMember 2023-10-01 2023-12-31 0001497649 GSTX:StockPayableMember 2023-10-01 2023-12-31 0001497649 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-01 2023-12-31 0001497649 2023-10-01 2023-12-31 0001497649 us-gaap:CommonStockMember 2023-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001497649 GSTX:StockReceivableMember 2023-12-31 0001497649 GSTX:StockPayableMember 2023-12-31 0001497649 us-gaap:RetainedEarningsMember 2023-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001497649 2023-12-31 0001497649 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001497649 GSTX:StockReceivableMember 2024-01-01 2024-03-31 0001497649 GSTX:StockPayableMember 2024-01-01 2024-03-31 0001497649 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001497649 2024-01-01 2024-03-31 0001497649 us-gaap:CommonStockMember 2024-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001497649 GSTX:StockReceivableMember 2024-03-31 0001497649 GSTX:StockPayableMember 2024-03-31 0001497649 us-gaap:RetainedEarningsMember 2024-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001497649 2024-03-31 0001497649 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001497649 GSTX:StockReceivableMember 2024-04-01 2024-06-30 0001497649 GSTX:StockPayableMember 2024-04-01 2024-06-30 0001497649 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001497649 us-gaap:CommonStockMember 2024-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001497649 GSTX:StockReceivableMember 2024-06-30 0001497649 GSTX:StockPayableMember 2024-06-30 0001497649 us-gaap:RetainedEarningsMember 2024-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001497649 us-gaap:CommonStockMember 2022-09-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001497649 GSTX:StockReceivableMember 2022-09-30 0001497649 GSTX:StockPayableMember 2022-09-30 0001497649 us-gaap:RetainedEarningsMember 2022-09-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001497649 2022-09-30 0001497649 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001497649 GSTX:StockReceivableMember 2022-10-01 2022-12-31 0001497649 GSTX:StockPayableMember 2022-10-01 2022-12-31 0001497649 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 2022-12-31 0001497649 2022-10-01 2022-12-31 0001497649 us-gaap:CommonStockMember 2022-12-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001497649 GSTX:StockReceivableMember 2022-12-31 0001497649 GSTX:StockPayableMember 2022-12-31 0001497649 us-gaap:RetainedEarningsMember 2022-12-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001497649 2022-12-31 0001497649 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001497649 GSTX:StockReceivableMember 2023-01-01 2023-03-31 0001497649 GSTX:StockPayableMember 2023-01-01 2023-03-31 0001497649 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001497649 2023-01-01 2023-03-31 0001497649 us-gaap:CommonStockMember 2023-03-31 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001497649 GSTX:StockReceivableMember 2023-03-31 0001497649 GSTX:StockPayableMember 2023-03-31 0001497649 us-gaap:RetainedEarningsMember 2023-03-31 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001497649 2023-03-31 0001497649 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001497649 GSTX:StockReceivableMember 2023-04-01 2023-06-30 0001497649 GSTX:StockPayableMember 2023-04-01 2023-06-30 0001497649 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001497649 us-gaap:CommonStockMember 2023-06-30 0001497649 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001497649 GSTX:StockReceivableMember 2023-06-30 0001497649 GSTX:StockPayableMember 2023-06-30 0001497649 us-gaap:RetainedEarningsMember 2023-06-30 0001497649 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001497649 2023-06-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2015-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2024-06-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2023-09-30 0001497649 us-gaap:NotesPayableOtherPayablesMember 2019-01-15 0001497649 us-gaap:NotesPayableOtherPayablesMember 2020-09-30 0001497649 us-gaap:ConvertibleNotesPayableMember 2024-06-30 0001497649 us-gaap:ConvertibleNotesPayableMember 2023-09-30 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2016-01-30 2016-02-01 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2017-01-31 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2024-06-30 0001497649 us-gaap:ConvertibleNotesPayableMember us-gaap:SecuredDebtMember 2023-09-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2023-12-31 0001497649 GSTX:FirstQuarterMember 2023-10-01 2023-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2024-06-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:FirstQuarterMember 2023-10-01 2023-12-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:SecondQuarterMember 2024-03-31 0001497649 GSTX:SecondQuarterMember 2024-01-01 2024-03-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:SecondQuarterMember 2024-06-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:SecondQuarterMember 2024-01-01 2024-03-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarterMember 2024-03-31 0001497649 GSTX:ThirdQuarterMember 2024-01-01 2024-03-31 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarterMember 2024-06-30 0001497649 GSTX:ConvertibleNotesPayableRelatedPartyMember GSTX:ThirdQuarterMember 2024-01-01 2024-03-31 0001497649 GSTX:AndrewLiangMember 2022-12-04 2022-12-05 0001497649 GSTX:AndrewLiangMember 2022-12-05 0001497649 GSTX:MiLabsPtyMember 2023-02-27 2023-02-28 0001497649 GSTX:MiLabsPtyMember 2023-02-28 0001497649 GSTX:MILabsPtyLtdMember GSTX:JasonMayMember GSTX:ManagementServicesMember 2023-10-01 2024-06-30 0001497649 GSTX:CSALiangPtyLtdMember GSTX:AndrewLiangMember GSTX:CorporateAdvisorServicesMember 2023-10-01 2024-06-30 0001497649 GSTX:SativusInvestmentsMember GSTX:PaulSaffronMember GSTX:ManagementServicesMember 2023-10-01 2024-06-30 0001497649 GSTX:MILabsPtyLtdMember GSTX:JasonMayMember GSTX:ManagementServicesMember 2024-06-24 2024-06-26 0001497649 GSTX:USThinFilmsCorporationMember GSTX:DavidHalsteadMember 2024-06-27 0001497649 GSTX:USThinFilmsCorporationMember GSTX:DavidHalsteadMember 2024-06-24 2024-06-27 0001497649 GSTX:DirectorsOfficersAffiliatesAndRelatedPartiesMember 2023-10-01 2024-06-30 0001497649 GSTX:DirectorsOfficersAffiliatesAndRelatedPartiesMember 2022-10-01 2023-06-30 0001497649 us-gaap:CommonStockMember 2023-10-01 2024-06-30 0001497649 us-gaap:TransferAgentMember 2023-10-01 2024-06-30 0001497649 GSTX:BoardOfDirectorsEmployeesAndConsultantsMember us-gaap:CommonStockMember 2023-10-01 2024-06-30 0001497649 GSTX:SettlementOfRelatedPartyAndAffiliatedDebtAndLiabilitiesMember 2023-10-01 2024-06-30 0001497649 GSTX:DavidHalsteadMember GSTX:DirectorsAnnualCompensationMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001497649 GSTX:AndrewLiangMember GSTX:DirectorsAnnualCompensationMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001497649 GSTX:CharlesWantrupMember GSTX:DirectorsAnnualCompensationMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001497649 GSTX:JeffreyFreedmanMember GSTX:DirectorsAnnualCompensationMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001497649 GSTX:HenosisLimitedMember GSTX:ShareSaleAndPurchaseAgreementMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001497649 GSTX:DavidHareMember GSTX:ConsultingAgreementMember us-gaap:SubsequentEventMember 2024-09-01 2024-09-30 0001497649 GSTX:KristiSteeleMember GSTX:ConsultingAgreementMember us-gaap:SubsequentEventMember 2024-09-29 2024-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended June 30, 2024

 

Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to __________

 

Commission File Number: 333-174194

  

GRAPHENE & SOLAR TECHNOLOGIES LTD
(Exact name of registrant as specified in its charter)

 

colorado   27-2888719
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)

 

11201 North Tatum Blvd., Suite 300

 Phoenix, AZ 85028

(Address of principal executive offices, including Zip Code)

 

(602) 388-8335

(Issuer’s telephone number, including area code)

 

Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No

 

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated Filer Accelerated Filer
Non-accelerated Filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

As of October 7, 2024, the registrant had 565,279,887 outstanding shares of common stock.

 

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

 

FORM 10-Q

 

TABLE OF CONTENTS

 

PART I — FINANCIAL INFORMATION Page
Item 1. Condensed Consolidated Balance Sheets (Unaudited)  1
Item 2. Condensed Consolidated Statements of Operations (Unaudited)  2
Item 3. Condensed Consolidated Statements of Changes in Stockholders’ Deficiency (Unaudited)  3
Item 4. Condensed Consolidated Statements of Cash Flows (Unaudited)  5
Item 5. Management’s Discussion and Analysis of Financial Condition and Results of Operations.  11
Item 6. Controls and Procedures.  15
     
PART II — OTHER INFORMATION  
Item 1 Legal Proceedings 17
Item 1A Risk Factors  17
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds  17
Item 3 Defaults on Senior Securities  17
Item 4 Mine Safety Disclosures  17
Item 5 Other Information  17
Item 6. Exhibits.  17
     
SIGNATURES 18

 

 

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS

 

       
   June 30,  September 30,
   2024
(Unaudited)
  2023
Assets          
Current Assets:          
Cash  $1,083   $1,094 
Prepaid expenses   11,393    11,108 
Total Current Assets   12,476    12,202 
Other Assets:          
Furniture and equipment, net of depreciation $79,291   706    937 
Other receivable   1,000    4,015 
Assets held for sale         976 
Total Assets  $14,182   $18,130 
           
Liabilities and Stockholders’ Deficit          
Current Liabilities:          
Accounts payable and other payable  $1,118,599   $1,273,453 
Accrued interest payable   208,512    184,851 
Due to related party   753,647    1,759,601 
Notes payable, $60,000 in default   60,000    60,000 
Notes payable – related party   53,543    71,713 
Convertible notes payable, $100,747 in default   100,747    100,747 
Convertible notes payable – related party, net of discount $8,560 and $0   79,949       
Liabilities held for sale         1,546,794 
Total Current Liabilities   2,374,997    4,997,159 
           
Total Liabilities  $2,374,997   $4,997,159 
           
Stockholders’ Deficit:          
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding            
Common stock: 800,000,000 shares authorized; $0.00001 par value; 451,269,917 and 421,292,610 shares issued and outstanding   4,513    4,213 
Additional paid-in capital   67,724,760    63,883,859 
Stock Receivable   (795,000)   (795,000)
Stock Payable            
Accumulated deficit   (69,538,679)   (68,375,078)
Accumulated other comprehensive income   243,591    302,977 
Total Stockholders’ Deficit   (2,360,815)    (4,979,029)
           
Total Liabilities and Stockholders’ Deficit  $14,182   $18,130 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

1

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME

(Unaudited)

 

             
   Three Months Ending June 30  Nine Months Ending June 30
   2024  2023  2024  2023
Revenues  $  $  $  $
             
Operating expenses                    
Professional Services   275,151    322,155    972,805    610,262 
General and administrative   29,674    76,099    68,598    130,737 
Total operating expenses   304,825    398,254    1,041,403    740,999 
                     
Loss from operations   (304,825)   (398,254)   (1,041,403)   (740,999)
                     
Other income (expense)                    
Other income   4,792    8,116    18,632    25,078 
Interest expense   (13,098)   (5,375)   (35,822)   (15,510)
Loss on extinguishment of debt   (1,700)   48    (1,700)   (40,393)
Total other income (expense)   (10,006)   2,789    (18,890)   (30,825)
                     
Discontinued Operations                    
Loss from Discontinued Operations   103,308          103,308       
                     
Net Income (Loss)  $(418,139)  $(395,465)  $(1,163,601)  $(771,824)
                     
Other Comprehensive Income  $(38,243)  $22,695   $(59,386)  $(35,194)
                     
Net Comprehensive Loss  $(456,382)  $(372,770)  $(1,222,987)  $(807,018)
                     
Income (Loss) per share:                    
Basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average shares outstanding   427,075,459    384,009,643    424,277,899    377,541,938 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

  

2

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Unaudited)

 

Three and Nine Months Ended June 30, 2024 and 2023

 

                                         
                    Accumulated   Total
  Common Stock  Additional  Stock  Stock  Accumulated’   Comprehensive   Stockholders
  Shares  Amount  Paid-in  Receivable  Payable  Deficit  Income  Deficit
Balance, September 30, 2023   421,292,610    4,213    63,883,859    (795,000)         (68,375,078)   302,977    (4,979,029)
Stock Based Compensation                           44,400                44,400 
Debt Discount on Notes Payable   600,000    6    11,577          7,096                18,679 
Foreign currency translation adjustment   —                                    (109,130)   (109,130)
Net loss   —                              (369,136)         (369,136)
Balance, December 31, 2023   421,892,610    4,219    63,895,436    (795,000)   51,496    (68,744,214)   193,847    (5,394,216)
Shares issued for cash   500,000    5    4,995                            5,000 
Stock Based Compensation   2,000,000    20    51,980                            52,000 
Debt Discount on Notes Payable   250,000    3    923                            926 
Debt Extinguishment   500,000    5    1,695                            1,700 
Foreign currency translation adjustment   —                                    87,987    87,987 
Net loss   —                              (376,326)         (376,326)
Balance, March 31, 2024   425,142,610    4,252    63,955,029    (795,000)   51,496    (69,120,540)   281,834    (5,622,929)
Shares issued for cash   200,000    2    1,998                            2,000 
Stock Based Compensation   10,500,000    105    109,669          (44,400)               65,374 
Debt Settlement   14,677,307    147    2,003,040                            2,003,187 
Debt Discount on Notes Payable   750,000    7    8,205          (7,096)               1,116 
Sale of Subsidiary   —            1,646,819                            1,646,819 
Foreign currency translation adjustment   —                                    (38,243)   (38,243)
Net loss   —                              (418,139)         (418,139)
Balance, June 30, 2024   451,269,917    4,513    67,724,760    (795,000)         (69,538,679)   243,591    (2,360,815)

 

 

3

 

 

                                         
                     Accumulated  Total
   Common Stock  Additional  Stock  Stock  Accumulated  Comprehensive  Stockholders
   Shares  Amount  Paid-in  Receivable  Payable  Deficit  Income  Deficit
Balance, September 30, 2022   374,305,480    3,748    63,527,513    (795,000)         (67,070,016)   290,563    (4,043,192)
Foreign currency translation adjustment   —                                    (74,455)   (74,455)
Net loss   —                              (176,458)         (176,458)
Balance, December 31, 2022   374,305,480    3,748    63,527,513    (795,000)         (67,246,474)   216,108    (4,294,105)
Settlement of Notes   237,130    3    65,208                            65,211 
Foreign currency translation adjustment   —                                    16,566    16,566 
Net loss   —                              (199,901)         (199,901)
Balance, March 31,2023   374,542,610    3,751    63,592,721    (795,000)         (67,446,375)   232,674    (4,412,229)
Stock Based Compensation   10,250,000    103    30,647                            30,750 
Foreign currency translation adjustment   —                                    22,695    22,695 
Net loss   —                              (395,465)         (395,465)
Balance, June 30, 2023   384,792,610    3,854    63,623,368    (795,000)         (67,841,840)   255,369    (4,754,249)

4

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the Nine-Month Period Ended June 30, 2024 and 2023

(Unaudited)

 

       
   2024  2023
Cash flows from operating activities          
Net Income (loss)  $(1,163,601)  $(771,824)
Adjustments to reconcile net income/(loss) to net cash from operating activities:          
Stock-based compensation   161,774    30,750 
Depreciation expense   252    254 
Loss on Debt Extinguishment   1,700       
Amortization of discount   12,161       
Loss on Settlement of Debt         40,393 
Change in operating assets and liabilities:          
Accounts payable   295,850    167,158 
Accrued interest payable   23,661    15,510 
Other Receivables   4,015    (1,921)
Pre-Payments            
Due to related parties   611,027    472,730 
Net cash used in operating activities   (53,161)   (46,950)
           
Cash flows from investing activities          
 Cash for sale of subsidiary            
Net cash used in investing activities            
           
Cash flows from financing activities          
Proceeds from issuance of common stock   7,000       
Due to Affiliates         51,694 
Issuance of convertible note – related party   70,399       
Net cash from financing activities   77,399    51,694 
           
Effect of currency translations to cash flow   (24,189)   (1,106)
Net change in cash and cash equivalents   (11)   3,638 
Beginning of period   1,094    2,857 
End of period  $1,083   $6,495 

 

Supplemental cash flow information  Quarter ended June 30,
   2024  2023
Interest paid  $     $   
Taxes  $     $   
Noncash investing and financing activities:          
Settlement of Debt for Common Stock   2,003,187    24,818 
Issuance of Common Stock as Debt Discount   20,721       

 

 

The accompanying notes are an integral part of these consolidated financial statements.

  

5

 

 

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

 

NOTE 1 – BASIS OF PRESENTATION

 

These consolidated financial statements of Graphene & Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar Technologies audited financial statements as of September 30, 2023.

 

Going Concern – The Company has incurred cumulative net losses since inception of $69,538,679 at June 30, 2024. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

 

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

 

Principles of Consolidation and Basis of Presentation – The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2023.

 

Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities.

 

6

 

Cash and Cash Equivalents – Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of June 30, 2024 and September 30, 2023, the Company had $1,083 and $1,094 in cash, respectively, and no cash equivalents.

 

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending June 30, 2024. Therefore, no derivative liabilities were recorded during the quarter ended June 30, 2024.

 

Stock-Based CompensationASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 

Earnings Per Share – Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 

Reclassifications – Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

 

Assets and Liabilities Held for Sale – Assets and liabilities are classified as held for sale when management commits to a plan to sell the asset or settle the liability, and it is probable that the sale will occur within one year. These assets and liabilities are measured at the lower of their carrying amount or fair value less costs to sell. Any adjustments to the carrying amounts are recognized in the period the asset is classified as held for sale.

7

 

 

NOTE 3 – NOTES PAYABLE

 

The Company’s indebtedness as of June 30, 2024 and September 30, 2023 were as follows:

 

          
Description 

June 30, 

2024

  September 30, 2023
       
Convertible notes  $100,747   $100,747 
Convertible notes – related party, net of discount $8,560   79,949       
Notes Payable  $60,000   $60,000 
Notes Payable – Related Parties  $53,543   $71,713 

 

Notes Payable and Other Loans

 

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of June 30, 2024 and September 30, 2023, the total promissory notes payable balance was $113,214 and $108,710 including accrued interest of $53,214 and $48,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

 

During the year ended September 30, 2020, a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

 

Convertible Notes Payable

 

As of June 30, 2024 and September 30, 2023, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of June 30, 2024 and September 30, 2023, the exchange obligation payable was $187,476 and $179,510 including accrued interest of $116,728 and $108,762, respectively. As of June 30, 2024 and September 30, 2023, the exchange obligation was for 56,639 shares and 54,233 shares of common stock, respectively. The Company has not extended the maturity dates and the notes are in default.

 

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per share. As of June 30, 2024 and September 30, 2023, the total convertible note payable balance was $55,249 and $52,997, including accrued interest of $25,249 and $22,997, respectively. As of June 30, 2024 and September 30, 2023, the exchange obligation was for 110,498 shares and 105,994 shares of common stock, respectively. The Company has not extended the maturity date and the note is in default.

 

Convertible Notes Payable – Related Party

 

During the quarter ended December 31, 2023, the Company entered into an agreement to issue convertible notes payable with an accredited investor. Notably, there exists a professional relationship between the Company and the investor, facilitated by a mutual director serving on the boards of both entities. These notes carry an aggregate principal balance of $50,000 and accrue interest at a rate of 10% per annum. Their maturity dates are set for October 2024 and December 2024. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $53,198, inclusive of accrued interest totaling $3,198. Moreover, the exchange obligation associated with these notes amounted to 531,980 shares of common stock. In return for providing the loan, the Company authorized and issued 1,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $18,679 upon the issuance of the notes, with subsequent amortization of debt discount totaling $11,862.

 

During the quarter ended March 31, 2024, the Company entered into agreements to issue a convertible note payable with a director serving on the board. The notes carry an aggregate principal balance of $27,828 and accrue interest at a rate of 10% per annum. Their maturity dates are set for March 2025. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $29,994, inclusive of accrued interest totaling $2,166. Moreover, the exchange obligation associated with these notes amounted to 299,940 shares of common stock. In return for providing the loan, the Company authorized and issued 500,000 shares of common stock to the lender. The Company recorded an initial debt discount of $2,493 upon the issuance of the notes, with subsequent amortization of debt discount totaling $681.

8

 

 

During the quarter ended June 30, 2024, the Company entered into agreements to issue a convertible note payable with a director serving on the board. The notes carry an aggregate principal balance of $10,681 and accrue interest at a rate of 10% per annum. Their maturity dates are set for June 2025. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $10,775, inclusive of accrued interest totaling $94. Moreover, the exchange obligation associated with these notes amounted to 107,750 shares of common stock. In return for providing the loan, the Company authorized and issued 350,000 shares of common stock to the lender. The Company recorded an initial debt discount of $1,116 upon the issuance of the notes, with subsequent amortization of debt discount totaling $57.

 

Related Party Loans

 

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum. To date, the note has not been paid.

 

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $33,543 was received by the company as of June 30, 2024) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum. To date, the note has not been paid.

 

NOTE 4- RELATED PARTY

 

MI Labs Pty Ltd, a management company controlled by Mr. Jason May, the Company’s Chief Executive Officer and a Company Director, provides management services to the Company for which the Company is charged $25,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $225,000 with respect to this arrangement.

 

CSA Liang Pty Ltd, a management company controlled by Mr. Andrew Liang, a Company Director, provided corporate advisor services to the Company for which the Company is charged $5,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $45,000 with respect to this arrangement.

 

Sativus Investments, a management company controlled by Mr. Paul Saffron, the Company’s Chief Operations Officer, provides management services to the Company for which the Company is charged $20,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $180,000 with respect to this arrangement.

 

Pagemark Limited, a management company controlled by Mr. David Halstead, a Company Director, entered into a convertible note agreement with the Company – see NOTE 3.

 

Allegro Investments Limited entered into a convertible note agreement with the Company. The Company and Allegro Investments Limited share a professional relationship wherein a director serves on the boards of both entities – see NOTE 3.

 

On June 26, 2024, a liability due of $1,536,006 was settled with Mr. Jason May in exchange for 10,005,500 shares.

 

On June 27, 2024, the Company sold US Thin-Films Corporation, a wholly owned subsidiary, to Thin Film Technologies Ltd., a company controlled by Mr. David Halstead, a Company Director, for $1,000. This transaction resulted in a gain of $1,646,819, which was recorded in Additional Paid-In Capital. Prior to the sale, the Company had a net liability of $1,645,819.

 

During nine-months period ended June 30, 2024 and 2023, stock-based compensation expense relating to directors, officers, affiliates and related parties was $184,685 (14,005,500 shares) and $0 (0 shares), respectively. 

 

9

 

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

29,977,307 new common shares were issued during the nine-month period ending June 30, 2024. The Company has a total of 5,778,367 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at June 30, 2024.

 

During the quarter ended June 30, 2024, the Company issued 25,727,307 shares of the Company’s common stock to members of the Board of Directors, employees, and consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, aggregated $340,741.

 

Total stock-based compensation expense was $161,775 for the nine-months ended June 30, 2024.

 

14,677,307 new common shares were issued during the nine-month period ending June 30, 2024 for settlement of related party and affiliated debt and liabilities totaling $2,003,187.

 

NOTE 6 – COMMITMENTS & CONTINGENCIES

 

Contingencies

 

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current, or future transactions or events. As of June 30, 2024, there were no pending or threatened litigation against the Company.

 

NOTE 7 – SALE OF US THIN-FILMS CORPORATION

 

During the quarter, US Thin-Films Corporation was sold to a related party entity for $1,000, resulting in a net liability of $1,645,819 being recognized – see NOTE 4. The sale of the entity resulted in the discontinued operations of US Thin-Films Corporation.

 

NOTE 8 – SUBSEQUENT EVENTS

 

Mr. David Halstead was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Andrew Liang was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Charles Wantrup was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Jeffrey Freedman was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Henosis Limited was granted 100,000,000 shares, per the terms of the Share Sale and Purchase Agreement dated July 28, 2024. The shares were issued in July 2024.

 

On June 26, 2024, a liability due of $200,997 was settled with Mr. Andrew Liang in exchange for 2,009,970 shares. The shares were issued in September 2024. 

 

Mr. David Hare was granted 2,500,000 shares, per the terms of his Consulting Agreement dated July 14, 2024. The shares were issued in September 2024.

 

Ms. Kristi Steele was granted 2,500,000 shares, per the terms of her Consulting Agreement dated July 14, 2024. The shares were issued in September 2024.

 

Haminerals Pty Ltd was granted 5,000,000 shares, per the terms of their Consulting Agreement dated May 01, 2024. The shares were issued in September 2024. 

 

The Company has evaluated events occurring subsequent to June 30, 2024 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

 

 

10

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

 

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

 

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

 

FORWARD LOOKING STATEMENTS

 

The information contained in this Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including among other things, statements regarding our capital needs, business strategy and expectations. Any statement which does not contain a historical fact may be deemed to be a forward-looking statement. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. In evaluating forward looking statements, you should consider various factors outlined in our Form 10-K report for the year ended September 30, 2023, filed with the U.S. Securities Exchange Commission (“SEC”) and, from time to time, in other reports we file with the SEC. These factors may cause our actual results to differ materially from any forward-looking statement. We disclaim any obligation to publicly update these statements or disclose any difference between our actual results and those reflected in these statements.

 

Overview

 

The core business of GSTX is manufacturing the materials and technologies for a greener more sustainable future. In line with the UN Sustainable Development Goals (https://sdgs.un.org/goals), the company is focused on two key sectors, energy and water. GSTX has established/acquired a portfolio of businesses specializing in using advanced manufacturing to make advanced materials for energy and water production. With a strong ESG focus the company is committed to establishing local manufacturing of tangible products for local markets.

 

In the energy space, the company is leveraging its existing business and management’s core competency to reshore solar manufacturing. The initial target markets are USA and Australia but exploring opportunities in Southeast Asia and Europe. A made locally approach.

 

The solar market is growing strongly (>10% annual growth). In addition to its strong environmental credentials, solar is now the cheapest form of electricity generation. The fundamental economics of solar are driving this market growth. With the market adoption, and price reductions, of short-term battery storage, many solar and battery installations are completely independent of grid-based distribution. Solar is a mature, proven technology.

During Q1 in the USA alone a record 11GW of solar was installed. This accounted for 75% of new energy installations in America. Currently in the US alone there are approximately 15GW of solar cell and panel manufacturing factories under construction. There are an additional approximate 15GW of factories in planning. The solar market in the USA at present is very strong. A solar panel is made up of multiple solar cells made from silicon wafers. At present 99% of all silicon wafers are made in China. US-based silicon wafer production and the majority of cell and panel production ceased over a decade ago. As a result, China completely dominates solar manufacturing. All but one of the new American based factories are relying on Chinese produced wafers for their production. GSTX plans to be the first company in production of American made silicon wafers during Q3/Q4 2025.

11

 

 

Silicon Wafer Manufacturing

 

The solar supply chain can be depicted as follows:

 

Quartz -> silicon -> polysilicon -> silicon ingots -> silicon wafers -> solar cells -> solar modules (panels)

 

GSTX has established a new, wholly owned, subsidiary, The Quartz & Silicon Materials Company Ltd (“QSM”) to hold its businesses involved in the solar manufacturing sector. QSM is the parent company for:

 

·Ausquartz Group Holdings (AUSQUARTZ) – An Australian based company with world class expertise in high purity quartz. Ausquartz operates a test and pilot production facility in Melbourne Australia. The company is successfully producing solar and semiconductor grade quartz sand.

 

·Wafer Manufacturing Company (WMC) – A USA based company developing silicon wafer manufacturing operations for supplying downstream solar cell manufacturers. WMC is a joint venture with American Solar Manufacturing Corporation.

 

·Southern Silicon – A New Zealand based company developing a silicon metal smelter and a polysilicon production plant on the South Island of New Zealand. These two facilities will utilise local resources and green (renewable) power.

 

These three key businesses provide an integrated supply chain for the production and delivery of silicon wafers. QSM is structured to take advantage of the American “Inflation Reduction Act” and the Australian “Made in Australia” programs to reshore critical solar manufacturing. Producing wafers locally (Made in America/Made in Australia) is key to being able to claim government incentives (production credits). QSM is a low technology risk enterprise, no new inventions, just manufacturing.

 

Water Harvesting

 

Water scarcity is at the center of the world’s most significant challenges. The United Nations estimates approximately 30% of the world’s population will face severe water shortages by 2025. Many people do not realise that the atmosphere, the air we breathe, contains a significant amount of water. Humidity is water in the air. Air can hold 1-2 ounces of water per cubic yard. At any one instant, the Earth’s atmosphere contains 37.5 trillion gallons of water vapor – enough to cover the entire surface of the planet with 1.5 inches of rain if condensed.

 

In parallel, massive population growth and urbanisation has led to an unprecedented demand for fresh water. Investment in infrastructure has been woefully inadequate, resulting in severe and critical water stress globally. There are an estimated 13 trillion litres (3.4 trillion gal) of water floating in the atmosphere at any one time. There is 6 times as much fresh water in the air as in all rivers and lakes in the world.

 

The Company is continuing commercialization of a unique water harvesting technology utilizing modular, self-contained units that can be solar or grid powered, and deployed in urban and rural environments. The water harvesters will extract moisture from the ambient air and collect as 100% pure fresh water. Each domestic water harvester will be capable of generating 30-50 liters (8-13 gal) of pure fresh water per day for personal use, with commercial models collecting up to 50,000 liters (13,000 gal) per day. The 100% pure H20 extracted from the atmosphere is also suitable for industrial use in green hydrogen production and pharmaceutical, semiconductor processing plants.

 

A 100% operational subsidiary has been established for the water harvesting products. It will trade as Adaquo, which is a Latin verb meaning to supply water. The company has engaged the services of two industry veterans (20+ years’ experience) to assist with commercialization of the technology.

 

Whilst still undertaking in house development of the company’s proprietary solid-state technology, the company is also exploring opportunities to license and distribute existing products that have been market proven on an exclusive geographical basis.

 

12

 

Graphene Material

 

The company has a strong interest in the downstream, commercial, applications of graphene. Unfortunately, the graphene sector has struggled to achieve significant commercial adoption of its materials. In addition, the scalable, bulk, production of graphene is also yet to be achieved at commercially economic levels. Graphene continues to show early stage promising technological improvements, but larger scale business opportunities remain elusive. GSTX management remain active in the sector and believe that graphene has a commercial future, but at present GSTX has paused actively developing its graphene opportunities. Graphene remains an interest of the company and continues to monitor the sector. The company remains interested in bulk production of graphene for the additive markets.

 

US Thin Films

 

GSTX has recently restructured its shareholding in US Thin-Film Corporation. GSTX is now a minority shareholder (19%) of US Thin-Film Corporation.

 

Applications of the proprietary thin film in existing electronics applications outperforms current materials. Key applications include: Electromagnetic Interference (EMI) Shielding, Flexible Transparent Antennas (4G/5G communications), Transparent Heaters (windows, goggles, etc), Touch Displays (monitors, phones, tablets), Photovoltaic, OLED Lighting, Flexible Displays, Sensors, and numerous other electronic applications The US Thin-Film technology is superior to traditional/existing technology with multiple times the electrical conductivity of conventional ITO based transparent conductive films with a simple manufacturing method protected by the company’s patent portfolio.

 

The company is presently in discussions with several contract manufacturing groups to produce initial samples of its thin film technology, branded Dragonfly film, for product qualification and pre-sales activity purposes.

 

Other areas of interest

 

The Company is also exploring acquisition opportunities for Critical Resource Assets (Minerals with identified supply chain risk), rare earth mineral extraction, zero emission fossil fuel replacement, green hydrogen, and ammonia production.

13

 

 

Results of Operations

 

For the fiscal quarters ended June 30, 2024 and 2023, we generated no revenues, and thus no cost of sales or gross profits.

 

For the fiscal quarters ended June 30, 2024 and 2023, we incurred $304,825 and $398,254, respectively, in operating expenses.

 

For the fiscal quarters ended June 30, 2024 we recorded other expenses of $14,798, while in the fiscal quarters ended June 30, 2023, we incurred expenses of $5,327; both items are represented by accrued interest on debt.

 

For the fiscal quarters ended June 30, 2024, we recorded other income of $4,792, while in the fiscal quarters ended June 30, 2023, we recorded other income of $8,116.

 

For the fiscal quarters ended June 30, 2024, $1,700 was recognized as gain on extinguishment of debt, while in the fiscal quarters ended June 30, 2023, we recorded $48.

 

For the nine-months ended June 30, 2024, we reported net loss before taxes of $418,139 while in the nine-months ended June 30, 2023, we reported a net loss before taxes of $395,465. Since there were no tax obligations in either year, net income / loss in each year was the same as that reported before taxes.

 

For the periods ended June 30, 2024 and September 30, 2023, our cash positions were $1,083 and $1,094, respectively.

 

As of June 30, 2024, we had total current liabilities of $2,374,997 while as of September 30, 2023, we had total current liabilities of $4,997,159 a decrease of about 110%. Accrued interest payable increased from $184,851 to $208,512 all attributable to accruals on the loans and the convertible notes payable. Related party debt decreased from $1,759,601 to $753,647 during the period.

 

Liquidity and Capital Resources

 

As of June 30, 2024, we had $12,476 in total current assets and $2,374,997 in total current liabilities. Accordingly, we had a working capital deficit of $2,362,521.

 

Cash used in operating activities was $53,161 for the nine-months ended June 30, 2024, as compared to $46,950 cash used in operating activities for the nine-months ended June 30, 2023.

 

Net cash provided by financing activities was $77,399 for the nine-months ended June 30, 2024, as compared to $51,694 for the nine-months ended June 30, 2023.

14

 

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements.

 

Critical Accounting Policies and Estimates

 

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 1.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

An evaluation was carried out under the supervision and with the participation of our management, including our Principal Executive and Interim Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Disclosure controls and procedures are procedures designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, such as this Form 10-Q, is recorded, processed, summarized and reported, within the time period specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and is communicated to our management, including our Principal Executive [and Financial Officer], or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our management concluded that, as of December 31, 2020, our disclosure controls and procedures were not effective.

 

Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020, based on the framework established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 (“COSO”).

 

As of period covered by this Quarterly Report on Form 10-Q, we have concluded that our internal control over financial reporting was ineffective. The Company’s assessment identified certain material weaknesses which are set forth below:

 

Functional Controls and Segregation of Duties

 

Because of the Company’s limited resources, there are limited controls over information processing.

 

There is an inadequate segregation of duties consistent with control objectives. Our Company’s management is composed of a small number of individuals resulting in a situation where limitations on segregation of duties exist. In order to remedy this situation, we would need to hire additional staff to provide greater segregation of duties. Currently, it is not feasible to hire additional staff to obtain optimal segregation of duties. Management will reassess this matter in the following year to determine whether improvement in segregation of duty is feasible.

 

Accordingly, as the result of identifying the above material weakness we have concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s internal controls.

 

Management’s Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of our Principal Executive and Financial Officer and implemented by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles.

15

 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Roger May, our former Principal Executive Officer, evaluated the effectiveness of our internal control over financial reporting as of December 31, 2020 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or the COSO Framework (2013). Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of those controls.

 

Changes in Internal Control Over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Management has addressed the underlying causes for our weaknesses in internal control since early FY 2020. Our efforts to raise both debt and equity capital soon will allow us to undertake additional engagement of external independent consultants to assist with the processing of data and drafting financial reports on a timely basis in future reporting periods.

 

16

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS

 

None.

 

ITEM 1A. RISK FACTORS

 

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our annual report on Form 10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Please see Note 5 to our Financial Statements.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibits

 

 

31.1 Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2 Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 Certification pursuant to Section 906 of the Sarbanes-Oxley Act.
   
32.2 Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

  

17

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  GRAPHENE & SOLAR TECHNOLOGIES LIMITED
     
Date: October 9, 2024 By: /s/ Jason May
    Chief Executive Officer and Director

 

  

18

 

 

 

 

EXHIBIT 31.1

 

CERTIFICATIONS

 

I, Jason May, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
   
2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 9, 2024 By: /s/ Jason May
    Jason May
    Chief Executive Officer and Director

 

 

 

 

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, David A.B. Halstead, certify that;

 

1. I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;
   
2. Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: October 9, 2024 By: /s/ David A.B. Halstead
    David A.B. Halstead
Chief Financial Officer and Director

 

 

 

 

EXHIBIT 32.1

 

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending June 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), Jason May, the Chief Executive Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

 

Date: October 9, 2024 By: /s/ Jason May
    Jason May
    Chief Executive Officer and Director

 

EXHIBIT 32.2

 

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending June 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), David A.B. Halstead, the Chief Financial Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
     
  (2) The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

 

Date: October 9, 2024 By: /s/ David A.B. Halstead
    David A.B. Halstead
    Chief Financial Officer and Director

 

v3.24.3
Cover - shares
9 Months Ended
Jun. 30, 2024
Oct. 07, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2024  
Current Fiscal Year End Date --09-30  
Entity File Number 333-174194  
Entity Registrant Name GRAPHENE & SOLAR TECHNOLOGIES LTD  
Entity Central Index Key 0001497649  
Entity Tax Identification Number 27-2888719  
Entity Incorporation, State or Country Code CO  
Entity Address, Address Line One 11201 North Tatum Blvd.  
Entity Address, Address Line Two Suite 300  
Entity Address, City or Town Phoenix  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85028  
City Area Code 602  
Local Phone Number 388-8335  
Entity Current Reporting Status Yes  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   565,279,887
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2024
Sep. 30, 2023
Current Assets:    
Cash $ 1,083 $ 1,094
Prepaid expenses 11,393 11,108
Total Current Assets 12,476 12,202
Other Assets:    
Furniture and equipment, net of depreciation $79,291 706 937
Other receivable 1,000 4,015
Assets held for sale 976
Total Assets 14,182 18,130
Current Liabilities:    
Accounts payable and other payable 1,118,599 1,273,453
Accrued interest payable 208,512 184,851
Due to related party 753,647 1,759,601
Notes payable, $60,000 in default 60,000 60,000
Notes payable – related party 53,543 71,713
Convertible notes payable, $100,747 in default 100,747 100,747
Convertible notes payable – related party, net of discount $8,560 and $0 79,949
Liabilities held for sale 1,546,794
Total Current Liabilities 2,374,997 4,997,159
Total Liabilities 2,374,997 4,997,159
Stockholders’ Deficit:    
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding
Common stock: 800,000,000 shares authorized; $0.00001 par value; 451,269,917 and 421,292,610 shares issued and outstanding 4,513 4,213
Additional paid-in capital 67,724,760 63,883,859
Stock Receivable (795,000) (795,000)
Stock Payable
Accumulated deficit (69,538,679) (68,375,078)
Accumulated other comprehensive income 243,591 302,977
Total Stockholders’ Deficit (2,360,815) (4,979,029)
Total Liabilities and Stockholders’ Deficit $ 14,182 $ 18,130
v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Jun. 30, 2024
Sep. 30, 2023
Statement of Financial Position [Abstract]    
Furniture and equipment, net of depreciation $ 79,291 $ 79,291
Note payable default 60,000 60,000
Convertible note payable default 100,747 100,747
Debt Instrument, Unamortized Discount, Current $ 8,560 $ 0
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, shares authorized 800,000,000 800,000,000
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares issued 451,269,917 421,292,610
Common stock, shares outstanding 451,269,917 421,292,610
v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2024
Jun. 30, 2023
Revenues        
Operating expenses                
Professional Services 275,151     322,155     972,805 610,262
General and administrative 29,674     76,099     68,598 130,737
Total operating expenses 304,825     398,254     1,041,403 740,999
Loss from operations (304,825)     (398,254)     (1,041,403) (740,999)
Other income (expense)                
Other income 4,792     8,116     18,632 25,078
Interest expense (13,098)     (5,375)     (35,822) (15,510)
Loss on extinguishment of debt (1,700)     48     (1,700) (40,393)
Total other income (expense) (10,006)     2,789     (18,890) (30,825)
Discontinued Operations                
Loss from Discontinued Operations 103,308         103,308
Net Income (Loss) (418,139) $ (376,326) $ (369,136) (395,465) $ (199,901) $ (176,458) (1,163,601) (771,824)
Other Comprehensive Income (38,243)     22,695     (59,386) (35,194)
Net Comprehensive Loss $ (456,382)     $ (372,770)     $ (1,222,987) $ (807,018)
Income (Loss) per share:                
Income (Loss) per share Basic $ (0.00)     $ (0.00)     $ (0.00) $ (0.00)
Income (Loss) per share Diluted $ (0.00)     $ (0.00)     $ (0.00) $ (0.00)
Weighted average shares outstanding basic 427,075,459     384,009,643     424,277,899 377,541,938
Weighted average shares outstanding diluted 427,075,459     384,009,643     424,277,899 377,541,938
Balance, March 31,2023 $ (5,622,929) (5,394,216) (4,979,029) $ (4,412,229) (4,294,105) (4,043,192) $ (4,979,029) $ (4,043,192)
Settlement of Notes         65,211      
Shares issued for cash 2,000 5,000            
Stock Based Compensation 65,374 52,000 44,400 30,750        
Debt Settlement 2,003,187              
Debt Discount on Notes Payable 1,116 926 18,679          
Sale of Subsidiary 1,646,819              
Debt Extinguishment   1,700            
Foreign currency translation adjustment (38,243) 87,987 (109,130) 22,695 16,566 (74,455)    
Net loss (418,139) (376,326) (369,136) (395,465) (199,901) (176,458) (1,163,601) (771,824)
Balance, June 30, 2023 (2,360,815) (5,622,929) (5,394,216) (4,754,249) (4,412,229) (4,294,105) (2,360,815) (4,754,249)
Common Stock [Member]                
Discontinued Operations                
Net Income (Loss)    
Income (Loss) per share:                
Balance, March 31,2023 $ 4,252 $ 4,219 $ 4,213 $ 3,751 $ 3,748 $ 3,748 $ 4,213 $ 3,748
Shares, Outstanding, Beginning Balance 425,142,610 421,892,610 421,292,610 374,542,610 374,305,480 374,305,480 421,292,610 374,305,480
Settlement of Notes         $ 3      
[custom:StockIssuedDuringPeriodSettlementOfNotesShares]         237,130      
Shares issued for cash $ 2 $ 5            
Stock Issued During Period, Shares, New Issues 200,000 500,000            
Stock Based Compensation $ 105 $ 20 $ 103        
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture 10,500,000 2,000,000 10,250,000        
Debt Settlement $ 147              
[custom:StockIssuedDuringPeriodDebtSettlementShares] 14,677,307              
Debt Discount on Notes Payable $ 7 $ 3 $ 6          
[custom:DebtDiscountOnNotesPayableShares] 750,000 250,000 600,000          
Sale of Subsidiary              
Debt Extinguishment   $ 5            
[custom:StockIssuedDuringPeriodDebtExtinguishmentShares]   500,000            
Foreign currency translation adjustment    
Net loss    
Balance, June 30, 2023 $ 4,513 $ 4,252 $ 4,219 $ 3,854 $ 3,751 $ 3,748 $ 4,513 $ 3,854
Shares, Outstanding, Ending Balance 451,269,917 425,142,610 421,892,610 384,792,610 374,542,610 374,305,480 451,269,917 384,792,610
Additional Paid-in Capital [Member]                
Discontinued Operations                
Net Income (Loss)    
Income (Loss) per share:                
Balance, March 31,2023 63,955,029 63,895,436 63,883,859 63,592,721 63,527,513 63,527,513 $ 63,883,859 $ 63,527,513
Settlement of Notes         65,208      
Shares issued for cash 1,998 4,995            
Stock Based Compensation 109,669 51,980 30,647        
Debt Settlement 2,003,040              
Debt Discount on Notes Payable 8,205 923 11,577          
Sale of Subsidiary 1,646,819              
Debt Extinguishment   1,695            
Foreign currency translation adjustment    
Net loss    
Balance, June 30, 2023 67,724,760 63,955,029 63,895,436 63,623,368 63,592,721 63,527,513 67,724,760 63,623,368
Stock Receivable [Member]                
Discontinued Operations                
Net Income (Loss)    
Income (Loss) per share:                
Balance, March 31,2023 (795,000) (795,000) (795,000) (795,000) (795,000) (795,000) (795,000) (795,000)
Settlement of Notes              
Shares issued for cash            
Stock Based Compensation        
Debt Settlement              
Debt Discount on Notes Payable          
Sale of Subsidiary              
Debt Extinguishment              
Foreign currency translation adjustment    
Net loss    
Balance, June 30, 2023 (795,000) (795,000) (795,000) (795,000) (795,000) (795,000) (795,000) (795,000)
Stock Payable [Member]                
Discontinued Operations                
Net Income (Loss)    
Income (Loss) per share:                
Balance, March 31,2023 51,496 51,496
Settlement of Notes              
Shares issued for cash            
Stock Based Compensation (44,400) 44,400        
Debt Settlement              
Debt Discount on Notes Payable (7,096) 7,096          
Sale of Subsidiary              
Debt Extinguishment              
Foreign currency translation adjustment    
Net loss    
Balance, June 30, 2023 51,496 51,496
Retained Earnings [Member]                
Discontinued Operations                
Net Income (Loss) (418,139) (376,326) (369,136) (395,465) (199,901) (176,458)    
Income (Loss) per share:                
Balance, March 31,2023 (69,120,540) (68,744,214) (68,375,078) (67,446,375) (67,246,474) (67,070,016) (68,375,078) (67,070,016)
Settlement of Notes              
Shares issued for cash            
Stock Based Compensation        
Debt Settlement              
Debt Discount on Notes Payable          
Sale of Subsidiary              
Debt Extinguishment              
Foreign currency translation adjustment    
Net loss (418,139) (376,326) (369,136) (395,465) (199,901) (176,458)    
Balance, June 30, 2023 (69,538,679) (69,120,540) (68,744,214) (67,841,840) (67,446,375) (67,246,474) (69,538,679) (67,841,840)
AOCI Attributable to Parent [Member]                
Discontinued Operations                
Net Income (Loss)    
Income (Loss) per share:                
Balance, March 31,2023 281,834 193,847 302,977 232,674 216,108 290,563 302,977 290,563
Settlement of Notes              
Shares issued for cash            
Stock Based Compensation        
Debt Settlement              
Debt Discount on Notes Payable          
Sale of Subsidiary              
Debt Extinguishment              
Foreign currency translation adjustment (38,243) 87,987 (109,130) 22,695 16,566 (74,455)    
Net loss    
Balance, June 30, 2023 $ 243,591 $ 281,834 $ 193,847 $ 255,369 $ 232,674 $ 216,108 $ 243,591 $ 255,369
v3.24.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities    
Net Income (loss) $ (1,163,601) $ (771,824)
Adjustments to reconcile net income/(loss) to net cash from operating activities:    
Stock-based compensation 161,774 30,750
Depreciation expense 252 254
Loss on Debt Extinguishment 1,700
Amortization of discount 12,161
Loss on Settlement of Debt 40,393
Change in operating assets and liabilities:    
Accounts payable 295,850 167,158
Accrued interest payable 23,661 15,510
Other Receivables 4,015 (1,921)
Pre-Payments
Due to related parties 611,027 472,730
Net cash used in operating activities (53,161) (46,950)
Cash flows from investing activities    
 Cash for sale of subsidiary
Net cash used in investing activities
Cash flows from financing activities    
Proceeds from issuance of common stock 7,000
Due to Affiliates 51,694
Issuance of convertible note – related party 70,399
Net cash from financing activities 77,399 51,694
Effect of currency translations to cash flow (24,189) (1,106)
Net change in cash and cash equivalents (11) 3,638
Beginning of period 1,094 2,857
End of period 1,083 6,495
Supplemental cash flow information    
Interest paid
Taxes
Noncash investing and financing activities:    
Settlement of Debt for Common Stock 2,003,187 24,818
Issuance of Common Stock as Debt Discount $ 20,721
v3.24.3
BASIS OF PRESENTATION
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

 

These consolidated financial statements of Graphene & Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar Technologies audited financial statements as of September 30, 2023.

 

Going Concern – The Company has incurred cumulative net losses since inception of $69,538,679 at June 30, 2024. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

 

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

 

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

 

Principles of Consolidation and Basis of Presentation – The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2023.

 

Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities.

 

Cash and Cash Equivalents – Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of June 30, 2024 and September 30, 2023, the Company had $1,083 and $1,094 in cash, respectively, and no cash equivalents.

 

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending June 30, 2024. Therefore, no derivative liabilities were recorded during the quarter ended June 30, 2024.

 

Stock-Based CompensationASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 

Earnings Per Share – Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 

Reclassifications – Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

 

Assets and Liabilities Held for Sale – Assets and liabilities are classified as held for sale when management commits to a plan to sell the asset or settle the liability, and it is probable that the sale will occur within one year. These assets and liabilities are measured at the lower of their carrying amount or fair value less costs to sell. Any adjustments to the carrying amounts are recognized in the period the asset is classified as held for sale.

 

v3.24.3
NOTES PAYABLE
9 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

 

The Company’s indebtedness as of June 30, 2024 and September 30, 2023 were as follows:

 

          
Description 

June 30, 

2024

  September 30, 2023
       
Convertible notes  $100,747   $100,747 
Convertible notes – related party, net of discount $8,560   79,949       
Notes Payable  $60,000   $60,000 
Notes Payable – Related Parties  $53,543   $71,713 

 

Notes Payable and Other Loans

 

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of June 30, 2024 and September 30, 2023, the total promissory notes payable balance was $113,214 and $108,710 including accrued interest of $53,214 and $48,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

 

During the year ended September 30, 2020, a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

 

Convertible Notes Payable

 

As of June 30, 2024 and September 30, 2023, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of June 30, 2024 and September 30, 2023, the exchange obligation payable was $187,476 and $179,510 including accrued interest of $116,728 and $108,762, respectively. As of June 30, 2024 and September 30, 2023, the exchange obligation was for 56,639 shares and 54,233 shares of common stock, respectively. The Company has not extended the maturity dates and the notes are in default.

 

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per share. As of June 30, 2024 and September 30, 2023, the total convertible note payable balance was $55,249 and $52,997, including accrued interest of $25,249 and $22,997, respectively. As of June 30, 2024 and September 30, 2023, the exchange obligation was for 110,498 shares and 105,994 shares of common stock, respectively. The Company has not extended the maturity date and the note is in default.

 

Convertible Notes Payable – Related Party

 

During the quarter ended December 31, 2023, the Company entered into an agreement to issue convertible notes payable with an accredited investor. Notably, there exists a professional relationship between the Company and the investor, facilitated by a mutual director serving on the boards of both entities. These notes carry an aggregate principal balance of $50,000 and accrue interest at a rate of 10% per annum. Their maturity dates are set for October 2024 and December 2024. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $53,198, inclusive of accrued interest totaling $3,198. Moreover, the exchange obligation associated with these notes amounted to 531,980 shares of common stock. In return for providing the loan, the Company authorized and issued 1,000,000 shares of common stock to the lender. The Company recorded an initial debt discount of $18,679 upon the issuance of the notes, with subsequent amortization of debt discount totaling $11,862.

 

During the quarter ended March 31, 2024, the Company entered into agreements to issue a convertible note payable with a director serving on the board. The notes carry an aggregate principal balance of $27,828 and accrue interest at a rate of 10% per annum. Their maturity dates are set for March 2025. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $29,994, inclusive of accrued interest totaling $2,166. Moreover, the exchange obligation associated with these notes amounted to 299,940 shares of common stock. In return for providing the loan, the Company authorized and issued 500,000 shares of common stock to the lender. The Company recorded an initial debt discount of $2,493 upon the issuance of the notes, with subsequent amortization of debt discount totaling $681.

 

During the quarter ended June 30, 2024, the Company entered into agreements to issue a convertible note payable with a director serving on the board. The notes carry an aggregate principal balance of $10,681 and accrue interest at a rate of 10% per annum. Their maturity dates are set for June 2025. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of June 30, 2024, the total balance of promissory notes payable stood at $10,775, inclusive of accrued interest totaling $94. Moreover, the exchange obligation associated with these notes amounted to 107,750 shares of common stock. In return for providing the loan, the Company authorized and issued 350,000 shares of common stock to the lender. The Company recorded an initial debt discount of $1,116 upon the issuance of the notes, with subsequent amortization of debt discount totaling $57.

 

Related Party Loans

 

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum. To date, the note has not been paid.

 

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $33,543 was received by the company as of June 30, 2024) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum. To date, the note has not been paid.

 

v3.24.3
RELATED PARTY
9 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY

NOTE 4- RELATED PARTY

 

MI Labs Pty Ltd, a management company controlled by Mr. Jason May, the Company’s Chief Executive Officer and a Company Director, provides management services to the Company for which the Company is charged $25,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $225,000 with respect to this arrangement.

 

CSA Liang Pty Ltd, a management company controlled by Mr. Andrew Liang, a Company Director, provided corporate advisor services to the Company for which the Company is charged $5,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $45,000 with respect to this arrangement.

 

Sativus Investments, a management company controlled by Mr. Paul Saffron, the Company’s Chief Operations Officer, provides management services to the Company for which the Company is charged $20,000 monthly. During the nine months ended June 30, 2024, the Company incurred charges to operations of $180,000 with respect to this arrangement.

 

Pagemark Limited, a management company controlled by Mr. David Halstead, a Company Director, entered into a convertible note agreement with the Company – see NOTE 3.

 

Allegro Investments Limited entered into a convertible note agreement with the Company. The Company and Allegro Investments Limited share a professional relationship wherein a director serves on the boards of both entities – see NOTE 3.

 

On June 26, 2024, a liability due of $1,536,006 was settled with Mr. Jason May in exchange for 10,005,500 shares.

 

On June 27, 2024, the Company sold US Thin-Films Corporation, a wholly owned subsidiary, to Thin Film Technologies Ltd., a company controlled by Mr. David Halstead, a Company Director, for $1,000. This transaction resulted in a gain of $1,646,819, which was recorded in Additional Paid-In Capital. Prior to the sale, the Company had a net liability of $1,645,819.

 

During nine-months period ended June 30, 2024 and 2023, stock-based compensation expense relating to directors, officers, affiliates and related parties was $184,685 (14,005,500 shares) and $0 (0 shares), respectively. 

 

v3.24.3
STOCKHOLDERS’ EQUITY
9 Months Ended
Jun. 30, 2024
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

 

29,977,307 new common shares were issued during the nine-month period ending June 30, 2024. The Company has a total of 5,778,367 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at June 30, 2024.

 

During the quarter ended June 30, 2024, the Company issued 25,727,307 shares of the Company’s common stock to members of the Board of Directors, employees, and consultants. The fair value of the shares, as determined by reference market price of the Company’s common stock on each grant date, aggregated $340,741.

 

Total stock-based compensation expense was $161,775 for the nine-months ended June 30, 2024.

 

14,677,307 new common shares were issued during the nine-month period ending June 30, 2024 for settlement of related party and affiliated debt and liabilities totaling $2,003,187.

 

v3.24.3
COMMITMENTS & CONTINGENCIES
9 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS & CONTINGENCIES

NOTE 6 – COMMITMENTS & CONTINGENCIES

 

Contingencies

 

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current, or future transactions or events. As of June 30, 2024, there were no pending or threatened litigation against the Company.

 

v3.24.3
SALE OF US THIN-FILMS CORPORATION
9 Months Ended
Jun. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]  
SALE OF US THIN-FILMS CORPORATION

NOTE 7 – SALE OF US THIN-FILMS CORPORATION

 

During the quarter, US Thin-Films Corporation was sold to a related party entity for $1,000, resulting in a net liability of $1,645,819 being recognized – see NOTE 4. The sale of the entity resulted in the discontinued operations of US Thin-Films Corporation.

 

v3.24.3
SUBSEQUENT EVENTS
9 Months Ended
Jun. 30, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

 

Mr. David Halstead was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Andrew Liang was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Charles Wantrup was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Mr. Jeffrey Freedman was granted 500,000 shares for Directors annual compensation for fiscal year 2023/2024. The shares were issued in July 2024.

 

Henosis Limited was granted 100,000,000 shares, per the terms of the Share Sale and Purchase Agreement dated July 28, 2024. The shares were issued in July 2024.

 

On June 26, 2024, a liability due of $200,997 was settled with Mr. Andrew Liang in exchange for 2,009,970 shares. The shares were issued in September 2024. 

 

Mr. David Hare was granted 2,500,000 shares, per the terms of his Consulting Agreement dated July 14, 2024. The shares were issued in September 2024.

 

Ms. Kristi Steele was granted 2,500,000 shares, per the terms of her Consulting Agreement dated July 14, 2024. The shares were issued in September 2024.

 

Haminerals Pty Ltd was granted 5,000,000 shares, per the terms of their Consulting Agreement dated May 01, 2024. The shares were issued in September 2024. 

 

The Company has evaluated events occurring subsequent to June 30, 2024 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

 

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies)
9 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Principles of Consolidation and Basis of Presentation

Principles of Consolidation and Basis of Presentation – The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2023.

 

Use of Estimates

Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities.

 

Cash and Cash Equivalents

Cash and Cash Equivalents – Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of June 30, 2024 and September 30, 2023, the Company had $1,083 and $1,094 in cash, respectively, and no cash equivalents.

 

Derivative Financial Instruments

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

 

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

 

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

 

There was no derivative activity in fiscal quarter ending June 30, 2024. Therefore, no derivative liabilities were recorded during the quarter ended June 30, 2024.

 

Stock-Based Compensation

Stock-Based CompensationASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

 

Foreign Currency Translations

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

 

Earnings Per Share

Earnings Per Share – Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

 

Reclassifications

Reclassifications – Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

 

Assets and Liabilities Held for Sale

Assets and Liabilities Held for Sale – Assets and liabilities are classified as held for sale when management commits to a plan to sell the asset or settle the liability, and it is probable that the sale will occur within one year. These assets and liabilities are measured at the lower of their carrying amount or fair value less costs to sell. Any adjustments to the carrying amounts are recognized in the period the asset is classified as held for sale.

 

v3.24.3
NOTES PAYABLE (Tables)
9 Months Ended
Jun. 30, 2024
Debt Disclosure [Abstract]  
Schedule of notes payable
          
Description 

June 30, 

2024

  September 30, 2023
       
Convertible notes  $100,747   $100,747 
Convertible notes – related party, net of discount $8,560   79,949       
Notes Payable  $60,000   $60,000 
Notes Payable – Related Parties  $53,543   $71,713 
v3.24.3
BASIS OF PRESENTATION (Details Narrative) - USD ($)
Jun. 30, 2024
Sep. 30, 2023
Accounting Policies [Abstract]    
Accumulated deficit $ 69,538,679 $ 68,375,078
v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
9 Months Ended
Jun. 30, 2024
Sep. 30, 2023
Accounting Policies [Abstract]    
Cash $ 1,083 $ 1,094
Derivative activity 0  
Derivative liabilities $ 0  
v3.24.3
NOTES PAYABLE (Details) - USD ($)
Jun. 30, 2024
Sep. 30, 2023
Debt Disclosure [Abstract]    
Convertible notes $ 100,747 $ 100,747
Convertible notes – related party, net of discount $8,560 79,949
Net of discount 8,560  
Notes Payable 60,000 60,000
Notes Payable – Related Parties $ 53,543 $ 71,713
v3.24.3
NOTES PAYABLE (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2023
Dec. 05, 2022
Feb. 01, 2016
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2023
Sep. 30, 2020
Jan. 15, 2019
Jan. 31, 2017
Sep. 30, 2016
Sep. 30, 2015
Short-Term Debt [Line Items]                          
Notes payable           $ 60,000   $ 60,000          
Convertible note payable           $ 100,747   $ 100,747          
Common stock, authorized           800,000,000   800,000,000          
Amortization of debt discount           $ 12,161            
Andrew Liang [Member]                          
Short-Term Debt [Line Items]                          
Interest rate   10.00%                      
Maturity dates   December 5, 2023                      
Related party loan amount   $ 20,000                      
Mi Labs Pty [Member]                          
Short-Term Debt [Line Items]                          
Interest rate 10.00%                        
Maturity dates February 28, 2024                        
Related party loan amount $ 50,000                        
First Quarter [Member]                          
Short-Term Debt [Line Items]                          
Maturity dates         October 2024 and December 2024                
Second Quarter [Member]                          
Short-Term Debt [Line Items]                          
Maturity dates       March 2025                  
Third Quarter [Member]                          
Short-Term Debt [Line Items]                          
Maturity dates       June 2025                  
Convertible Notes Payable [Member]                          
Short-Term Debt [Line Items]                          
Accrued interest           116,728   $ 108,762          
Outstanding principal amount           70,747   70,747          
Exchange obligation payable           $ 187,476   $ 179,510          
Exchange obligation shares           56,639   54,233          
Convertible Notes Payable [Member] | Secured Debt [Member]                          
Short-Term Debt [Line Items]                          
Interest rate                     10.00%    
Accrued interest           $ 25,249   $ 22,997          
Exchange obligation shares           110,498   105,994          
Issued convertible secured note payable     $ 30,000                    
Common shares per share           $ 0.50              
Convertible note payable           $ 55,249   $ 52,997          
Convertible Notes Payable Related Party [Member] | First Quarter [Member]                          
Short-Term Debt [Line Items]                          
Principal amount         $ 50,000                
Interest rate         10.00%                
Accrued interest           3,198              
Conversion rate of per share         $ 0.10                
Total balance of promissory notes payable           53,198              
Exchange obligation shares         531,980                
Common stock, authorized         1,000,000                
Initial debt discount         $ 18,679                
Amortization of debt discount         $ 11,862                
Convertible Notes Payable Related Party [Member] | Second Quarter [Member]                          
Short-Term Debt [Line Items]                          
Principal amount       $ 27,828                  
Interest rate       10.00%                  
Accrued interest           2,166              
Conversion rate of per share       $ 0.10                  
Total balance of promissory notes payable           29,994              
Exchange obligation shares       299,940                  
Common stock, authorized       500,000                  
Initial debt discount       $ 2,493                  
Amortization of debt discount       681                  
Convertible Notes Payable Related Party [Member] | Third Quarter [Member]                          
Short-Term Debt [Line Items]                          
Principal amount       $ 10,681                  
Interest rate       10.00%                  
Accrued interest           94              
Conversion rate of per share       $ 0.10                  
Total balance of promissory notes payable           10,775              
Exchange obligation shares       107,750                  
Common stock, authorized       350,000                  
Initial debt discount       $ 1,116                  
Amortization of debt discount       $ 57                  
Notes Payable, Other Payables [Member]                          
Short-Term Debt [Line Items]                          
Principal amount                   $ 10,000   $ 60,000 $ 60,000
Interest rate                       10.00% 10.00%
Notes payable           113,214   108,710          
Accrued interest           $ 53,214   $ 48,710          
Advisor loaned amount                 $ 5,781        
v3.24.3
RELATED PARTY (Details Narrative) - USD ($)
9 Months Ended
Jun. 27, 2024
Jun. 26, 2024
Jun. 30, 2024
Jun. 30, 2023
David Halstead [Member] | U S Thin Films Corporation [Member]        
Related Party Transaction [Line Items]        
Consideration amount $ 1,000      
Gain 1,646,819      
Net liability $ 1,645,819      
Directors Officers Affiliates And Related Parties [Member]        
Related Party Transaction [Line Items]        
Stock-based compensation expense     $ 184,685 $ 0
Issued shares     14,005,500 0
M I Labs Pty Ltd [Member] | Jason May [Member] | Management Services [Member]        
Related Party Transaction [Line Items]        
Monthly charged amount     $ 25,000  
Incurred charges to operations     225,000  
Settled amount   $ 1,536,006    
Exchange shares   10,005,500    
C S A Liang Pty Ltd [Member] | Andrew Liang [Member] | Corporate Advisor Services [Member]        
Related Party Transaction [Line Items]        
Monthly charged amount     5,000  
Incurred charges to operations     45,000  
Sativus Investments [Member] | Paul Saffron [Member] | Management Services [Member]        
Related Party Transaction [Line Items]        
Monthly charged amount     20,000  
Incurred charges to operations     $ 180,000  
v3.24.3
STOCKHOLDERS’ EQUITY (Details Narrative)
9 Months Ended
Jun. 30, 2024
USD ($)
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Stock-based compensation expense | $ $ 161,775
Settlement Of Related Party And Affiliated Debt And Liabilities [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Shares issued 14,677,307
Aggregated amount | $ $ 2,003,187
Transfer Agent [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Reserved and outstanding and not yet issued 5,778,367
Common Stock [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Shares issued 29,977,307
Common Stock [Member] | Board Of Directors Employees And Consultants [Member]  
Accumulated Other Comprehensive Income (Loss) [Line Items]  
Shares issued 25,727,307
Aggregated amount | $ $ 340,741
v3.24.3
COMMITMENTS & CONTINGENCIES (Details Narrative)
9 Months Ended
Jun. 30, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Pending or threatened litigation $ 0
v3.24.3
SALE OF US THIN-FILMS CORPORATION (Details Narrative) - U S Thin Films Corporation [Member] - David Halstead [Member]
Jun. 27, 2024
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Consideration amount $ 1,000
Net liability $ 1,645,819
v3.24.3
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - shares
1 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Jul. 31, 2024
David Halstead [Member] | Directors Annual Compensation [Member]      
Subsequent Event [Line Items]      
Granted shares     500,000
Andrew Liang [Member] | Directors Annual Compensation [Member]      
Subsequent Event [Line Items]      
Granted shares     500,000
Charles Wantrup [Member] | Directors Annual Compensation [Member]      
Subsequent Event [Line Items]      
Granted shares     500,000
Jeffrey Freedman [Member] | Directors Annual Compensation [Member]      
Subsequent Event [Line Items]      
Granted shares     500,000
Henosis Limited [Member] | Share Sale And Purchase Agreement [Member]      
Subsequent Event [Line Items]      
Granted shares     100,000,000
David Hare [Member] | Consulting Agreement [Member]      
Subsequent Event [Line Items]      
Granted shares   2,500,000  
Kristi Steele [Member] | Consulting Agreement [Member]      
Subsequent Event [Line Items]      
Granted shares 2,500,000    

Graphene and Solar Techn... (PK) (USOTC:GSTX)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Graphene and Solar Techn... (PK) Charts.
Graphene and Solar Techn... (PK) (USOTC:GSTX)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Graphene and Solar Techn... (PK) Charts.